Investors may have been looking at gaining more exposure to financial stocks – and banks in particular – as the US continues on a path of rising interest rates, while the Trump administration pushes a deregulatory agenda. However, as our financials analyst Paul Schenk wrote in January, we remain cautious. The rally which has taken place over the last six months means, we think, that the US banking sector is now pricing in many of the anticipated benefits: it is now trading on a 16.4x forward price-to-earnings (P/E) ratio versus an average of just over 12x historically.[1]

While a simpler regulatory rulebook and less onerous scrutiny would be helpful for the industry, we remain sceptical about the prospects for any major relaxation of regulatory capital requirements. Initial proposals (such as the Financial CHOICE Act) indicate the potential for leverage ratios to become a bigger part of the capital regime – thereby arguing for higher rather than lower capital levels.

The US banking industry remains highly fragmented, and our view is that any margin benefit from higher interest rates is likely to be competed away over time as the industry is broadly priced for a reasonable return on equity (ROE) rather than a maximal ROE – as we have seen historically through varying US interest-rate cycles.

However, we do see opportunities in other parts of the US financial sector where there are suggestions that regulation on selling practices will be eased. For instance, the Trump administration recently ordered a review of Department of Labor (DOL) regulation on providing advice, which was set to come into effect in April. If this measure, known as the fiduciary rule, is revised or rescinded, companies selling savings products could benefit.

Emerging opportunities

We also see several opportunities in the insurance sector, where there is less pressure on the industry. In particular, we believe Asian savings and health insurance represent a significant growth opportunity owing to a low penetration of health-care products and lack of state-sponsored health care; in addition, GDP per capita levels are just reaching the point where insurance penetration rates tend to accelerate.



Lastly, as global investors, we see opportunities in less mainstream markets with the prospect of higher growth and more attractive sustainable returns which are not fully reflected in current valuations. These include banks in Georgia, and mortgage-finance companies in India, where mortgage debt is currently only 9% of GDP, compared to 88% in the UK, thereby providing a long ‘runway’ for future potential growth.


[1] Source: US banking (BKX) index – Bloomberg


Your email address will not be published.

Newton does not capture and store any personal information about an individual who accesses this blog, except where he or she volunteers such information, whether via email, an electronic form or other means. Where personal information is supplied, it will be used only in relation to this blog, and will not be collected or stored for any other purpose. Comments submitted via the blog are moderated, and, as a result, there may be a delay before they are posted.

Any reference to a specific security, country or sector should not be construed as a recommendation to buy or sell investments in those countries or sectors. Compared to more established economies, the value of investments in emerging markets may be subject to greater volatility due to differences in generally accepted accounting principles or from economic, political instability or less developed market practices.